Quality of life with adjuvant gefitinib versus vinorelbine plus cisplatin in patients with completely resected stage II–IIIA (N1–N2) EGFR-mutant non-small-cell lung cancer: Results from the ADJUVANT (CTONG1104) study
Titel:
Quality of life with adjuvant gefitinib versus vinorelbine plus cisplatin in patients with completely resected stage II–IIIA (N1–N2) EGFR-mutant non-small-cell lung cancer: Results from the ADJUVANT (CTONG1104) study
Auteur:
Zeng, Jian Mao, Wei-Min Chen, Qi-Xun Luo, Tao-Bo Wu, Yi-Long Zhou, Qing Yang, Xue-Ning Yan, Hong-Hong Zhong, Wen-Zhao Wang, Qun Xu, Song-Tao Wu, Lin Shen, Yi Liu, Yong-Yu Chen, Chun Cheng, Ying Xu, Lin Wang, Jun Fei, Ke Li, Xiao-Fei Li, Jian Huang, Cheng Liu, Zhi-Dong Xu, Shun Chen, Ke-Neng Xu, Shi-Dong Liu, Lun-Xu Yu, Ping Wang, Bu-Hai Ma, Hai-Tao